Stay updated on TAPUR Study: Targeted Drug Clinical Trial
Sign up to get notified when there's something new on the TAPUR Study: Targeted Drug Clinical Trial page.

Latest updates to the TAPUR Study: Targeted Drug Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedRevision history now shows v3.3.2 added and v3.3.1 removed.SummaryDifference0.0%

- Check25 days agoChange DetectedPublications section now notes that entries are auto-filled from PubMed and includes a revision note (v3.3.1). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check32 days agoChange DetectedRemoved the site-wide notice about government funding lapses and potential delays from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check46 days agoChange DetectedScreenshots reflect only superficial layout and styling differences on the Study Details page. There are no changes to core study information (arms, primary outcomes, eligibility criteria, enrollment, or participating sites).SummaryDifference0.1%

- Check76 days agoChange DetectedAdded numerous contact emails/phones and the term "Multiple myeloma" along with a website domain; removed "Plasma cell myeloma" and downgraded revision tag from v3.0.2 to v3.2.0. Minor overall content expansion with a small terminology refinement.SummaryDifference0.1%

- Check77 days agoChange DetectedSignificant addition of widespread contact emails/phone numbers and the term “Multiple myeloma”; removal of the term “Plasma cell myeloma” and an older revision label. The core meaning shifts toward expanded contact information rather than core content changes.SummaryDifference0.1%

Stay in the know with updates to TAPUR Study: Targeted Drug Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TAPUR Study: Targeted Drug Clinical Trial page.